Katherine Shamel, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 85 Spring St, Laconia, NH 03246 Phone: 603-524-7402 |
Kelley Watkins, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 22 Strafford St, Laconia, NH 03246 Phone: 603-366-1070 |
Carolyn Brown, FNP-C ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-524-3211 Fax: 603-527-7038 |
Tami Hayhurst, PMHNP, MSN Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 40 Beacon St E, Laconia, NH 03246 Phone: 603-542-1100 Fax: 603-524-5795 |
Virginia A Blackmer, ARNP Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-524-3211 |
News Archive
According to a new sub-analysis from the ACCENT I (A Crohn's disease Clinical trial Evaluating infliximab in a New long-term Treatment regimen) trial patients who received a three-dose induction regimen of Remicade experienced a significantly greater reduction in pain as assessed by four different pain questions after ten weeks, compared with patients who received a single dose of Remicade.
A ban on displays of tobacco is coming into force in England. Ministers hope it will help curb the number of young people taking up smoking. Cigarettes and other products will have to be kept below the counter in large shops and supermarkets, while small outlets are exempt until 2015. Other parts of the UK are planning similar action to drive down smoking rates.
PeriGen, Inc., the only OB-specific risk reduction company to provide solutions which generate immediate quantifiable clinical and financial value, today announced the formation of a strategic alliance with Willis Group Holdings, a leading global insurance broker and one of the world's largest professional services firms specializing in risk management.
Overexpression of programmed death-ligand 1 is independently associated with the presence of epidermal growth factor receptor gene mutations and poor prognosis in patients with non-small-cell lung cancer, Japanese researchers report.
› Verified 6 days ago